A detailed history of Scp Investment, LP transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Scp Investment, LP holds 2,500,000 shares of AMRN stock, worth $1.18 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares
2,500,000
Previous 2,500,000 -0.0%
Holding current value
$1.18 Million
Previous $1.72 Million 8.64%
% of portfolio
1.16%
Previous 1.1%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Mar 14, 2024

SELL
$0.66 - $0.91 $330,000 - $455,000
-500,000 Reduced 16.67%
2,500,000 $2.18 Million
Q4 2023

Feb 06, 2024

SELL
$0.66 - $0.91 $330,000 - $455,000
-500,000 Reduced 16.67%
2,500,000 $2.18 Million
Q3 2023

Mar 14, 2024

BUY
$0.85 - $1.43 $425,000 - $715,000
500,000 Added 20.0%
3,000,000 $2.76 Million
Q3 2023

Oct 31, 2023

SELL
$0.85 - $1.43 $2.98 Million - $5.01 Million
-3,500,000 Reduced 53.85%
3,000,000 $2.76 Million
Q4 2022

Feb 06, 2023

BUY
$1.07 - $1.34 $2.41 Million - $3.02 Million
2,250,000 Added 52.94%
6,500,000 $7.87 Million
Q3 2022

Oct 25, 2022

BUY
$1.09 - $1.67 $1.64 Million - $2.51 Million
1,500,000 Added 54.55%
4,250,000 $4.63 Million
Q2 2022

Jul 28, 2022

SELL
$1.13 - $3.69 $4.52 Million - $14.8 Million
-4,000,000 Reduced 59.26%
2,750,000 $4.1 Million
Q2 2021

Aug 11, 2021

BUY
$4.26 - $6.5 $5.33 Million - $8.13 Million
1,250,000 Added 22.73%
6,750,000 $29.6 Million
Q4 2020

Feb 12, 2021

BUY
$4.04 - $5.31 $12.1 Million - $15.9 Million
3,000,000 Added 120.0%
5,500,000 $26.9 Million
Q3 2020

Nov 12, 2020

BUY
$3.64 - $7.76 $9.1 Million - $19.4 Million
2,500,000 New
2,500,000 $10.5 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $190M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Scp Investment, LP Portfolio

Follow Scp Investment, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scp Investment, LP, based on Form 13F filings with the SEC.

News

Stay updated on Scp Investment, LP with notifications on news.